Verona Clinical Research: Current Studies

Volunteer With Verona Clinical Research

The physicians at Verona Clinical Research have participated in and may have current research studies involving the areas below.

To participate in our studies call us at 520.296.0918 to set up an appointment, or sign up online to become a volunteer.

Please don't hesitate to contact us for additional information.

Verona's primary goals are to establish a reputation for superior research, an unparalleled standard of ethics, and outstanding patient recruitment and retention.

Current Areas of Study

Chlamydia
COPD
Hypoactive Sexual Desire Disorder - Female
Irritable Bowel Syndrome
Over-Active Bladder

Chlamydia

About the study drug

Chlamydia is one of the most frequent treatable causes of genital tract
infections in the United States. People with Chlamydia are often treated with
doxycycline tablets twice a day, for 7 days.

Verona Clinical Research is conducting a study to find out if an
investigational medicine is safe and effective in people with Chlamydia. The
investigational medicine, a controlled-release form of doxycycline, is taken
only once a day for 7 days.

What does the study require from you?

If you agree to take part in this study, you will be randomly assigned (like
flipping a coin) to one of the following two groups:

Investigational Medication, once/day for 7 days
Doxycycline, twice/day for 7 days.

How many visits?

The study lasts a total of 28 days. There are three clinic visits in this study. At the initial visit you will be asked to sign a consent form and provide your
medical, surgical, and medication history.

The following will also be done during the course of the study:

Heart rate and temperature
Physical exam including genital exam and weight
Urine pregnancy test and vaginal swabs for sexually transmitted
disease (women only)
Urine test for sexually transmitted disease (men only)
Blood tests (total volume of blood drawn each time is about 5
teaspoonfuls)

Key Eligibility Criteria

Men and Women who satisfy the following criteria may participate:

19-45 years of age
Confirmed diagnosis of urogenital Chlamydia infection within the last 14 days
Willingness to abstain from alcohol during the study period (28 days).
Willingness to abstain from all sexual activity or use condoms during all sexual activity for the duration of the study (28 days).

Subjects with any of the following will be excluded:

Clinical diagnosis of pelvic inflammatory disease or epididymitis at the initial visit
Known diagnosis of any of the following:
- N. gonorrhea
- HIV infection
- Hepatitis B or C infection
- Known intolerance to tetracycline
- Pregnancy or breast feeding
- Prior hysterectomy

You will receive study drug free of charge during this study. Procedures that
are done only for this study, urine and blood lab tests, will not be billed to
you.

You will receive payment for time and travel.

COPD

We are inviting you to join this study because you have Chronic Obstructive Pulmonary Disease, often called COPD, and you have been hospitalized recently for it. The purpose of this study is to compare two types of study drugs in people who have recently been hospitalized for COPD.

The study will compare two investigational medications. Both drugs have been approved for sale and are indicated for treatment of COPD in the United States by the U.S. Food and Drug Administration (FDA).

What does the study require from you?

If you agree to take part in this study, you will be randomly assigned (like flipping a coin) to one of two groups to help determine whether one study drug is better than the other at preventing post-hospitalization exacerbation of COPD.

How many visits?

The study lasts a total of 34 weeks. There are five clinic visits in this study. At the initial visit you will be asked to sign a consent form and provide your medical, surgical, and medication history.

The following will also be done during the course of the study:

Electrocardiogram (ECG)
Physical exam
Chest X-ray or CT scan review
Breathing Test (Spirometry) to check your COPD
Vital signs: Weight, height, blood pressure, and pulse
Blood Tests: total volume of blood drawn each time is about 5 teaspoonfuls
Questionnaire: you will maintain a day-to-day diary about your health and cigarette smoking.

Study drug and procedures that are done only for this study (urine and blood lab tests) will not be billed to you.

You will receive payment for time and travel.

Key Eligibility Criteria

Men and Women who satisfy the following criteria may participate:

≥ 40 years of age
Subjects must have been hospitalized for COPD within the last 10 days OR
been treated and held in the ER for at least 24 hrs for COPD within the last 10 days OR
been treated with oral corticosteroids for treatment of COPD within the last 10 days and been hospitalized within the past 6 months due to COPD

Subjects with any of the following will be excluded:

Current clinical diagnosis of pneumonia, or congestive heart failure (CHF)
Known diagnosis of any of the following:

Lung cancer
Asthma as primary diagnosis
Cystic fibrosis, pulmonary fibrosis, active tuberculosis or sacoidosis
Cardiac arrhythmias
Unstable Angina
Other cancer or previous history of cancer in remission for < 5 years (some skin cancers OK)
Immunologic compromise
Cushing’s or Addison’s disease<

Contact:

Verona Clinical Research, Inc.
6565 E. Carondelet Drive, Ste. 285
Tucson, AZ 85710
520-885-8633

Hypoactive Sexual Desire Disorder - Female

Verona Clinical Research is conducting a clinical research study of a non-hormonal investigational oral drug compared with placebo for use in postmenopausal women suffering from hypoactive sexual desire (HSSD) which is a form of sexual dysfunction.

The following criteria (and others) may qualify you to participate in this research:

Have gone through natural menopause (menopause not due to surgery that removed both ovaries, radiation, etc.).
You are in a stable, monogamous, heterosexual relationship for at least one year.
Partner is sexually functional.
Your main sexual dysfunction when evaluated at the research center is hypoactive sexual desire (HSSD) which includes deficient or absent sexual fantasies and desire for sexual activity to the degree that it is causing marked distress or interpersonal difficulty.

If you believe you may meet the above selection criteria please contact Verona Clinical Research and a study coordinator will speak with you, ask you a series of questions to confirm you may qualify, and schedule you for a visit to meet with a study physician for more complete evaluation.

Qualifying participants will receive at no cost physical examination; pap test, pelvic ultrasound, and mammogram where required; plus study drug or placebo. Payment for time and travel may be available.

Here is the contact information:

Verona Clinical Research, Inc.
6565 E. Carondelet Drive Suite 285
Tucson, Arizona 85710
Phone: (520) 296-0918

Irritable Bowel Syndrome

Verona Clinical Research, Inc. is conducting a research study to evaluate the safety and effectiveness of an experimental medication compared to placebo (an inactive substance) for the treatment of patients with irritable bowel syndrome with diarrhea, or IBS-D.

There will be approximately 8 office visits over 18 weeks. Qualified participants will receive study medication or placebo, study-related testing, physical exams, and lab work at no charge. Compensation may be available to qualified participants for each completed visit (for time and travel).

If you are interested in this study, you should:

Be between the ages 18-65 years old
Have diarrhea predominant irritable bowel syndrome
Have had a colonoscopy or flexible sigmoidoscopy in the last 5 years

If you would like to learn more about this study, please call us at 520-885-8633. One of our staff will be give you more details regarding study visits and procedures. If you are still interested after speaking with us, then we will schedule an appointment to meet with our Physician to see if you qualify for the study.

We appreciate your interest in this opportunity and look forward to meeting you.

Verona Clinical Research, Inc.
6565 E. Carondelet Drive, Suite 285
Tucson, AZ 85710
520-885-8633

Over-Active Bladder

Verona Clinical Research is conducting a clinical research study evaluating an approved medication for people 65 or older with overactive bladder.

Some of the criteria you would be required to meet in order to qualify to participate in this study include:

Men and Women age 65 or older.
If age is 65 – 84, must be experiencing difficulty with physical activities and tasks. (Age 85 and older need not meet this requirement).
Overactive bladder symptoms for 3 or more months.
Experience frequent wetting episodes.

Study participation includes:

Study-related Physical exam, lab testing, ECG.
Study drug or inactive placebo.
Payment for time and travel.

If you take part in this research study, you will attend five office visits over a 14-week period.

To learn more call (520) 296-0918. Our staff will give you further information, ask you some questions to see if you may qualify, and make an appointment with a Verona Clinical Research study physician to discuss the study in greater detail. We look forward to meeting you.